Exam 2 - Pulmonary Pharmacology Flashcards

1
Q

bronchodilators class

A
  • beta2 agonists
  • anticholinergics
  • xanthine derivatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

anti-inflammatories class

A
  • leukotriene receptor antagonist (LTRAs)
  • inhaled glucocorticoids
  • mast cell stabilizers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do bronchodilators do

A
  • used to treat ALL respiratory diseases
  • work by relaxing bronchial smooth muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

short acting beta-adrenergic agonists

A
  • albuterol
  • levalbuterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

long acting beta-adrenergic agonists

A
  • salmetrol
  • formoterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA: beta-adrenergic agonist

A
  • mimic action of SNS: fight or flight
  • relax and dilate the airways by stimulating the beta2-adrenergic receptors throughout the lungs
  • bronchial dilation and increased airflow into and out of the lungs is the goal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when are beta-adrenergic agonist contraindicated

A
  • uncontrolled hypertension
  • cardiac dysrhythmias
  • high risk for stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

albuterol

A
  • short acting beta2 agonist
  • RESCUE DRUG
  • treatment of ACUTE episodes of wheezing, chest tightness, SOA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does use of more than one canister of albuterol a month indicate

A
  • inadequate control of asthma and need for initiating or intensifying anti-inflammatory therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

salmeterol

A
  • long acting beta2 agonist
  • not for acute treatments, this is a maintenance drug
  • given twice a day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

salmeterol warning

A
  • has been associated with increased asthma-related deaths
  • more common in black/african Americans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

indications for salmeterol

A
  • worsening of COPD
  • moderate to severe asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is salmeterol always given with

A
  • an inhaled corticosteroid, not indicated for monotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does giving anticholinergics result in

A
  • turning off cholinergic response (PNS) and turning on SNS
  • SNS dominates = bronchodilaton
  • perfuses increases to heart, lungs, and brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is a key point with anticholinergics

A
  • blocking the effect of acetylcholine, we inhibit the normal physiological response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anticholinergic drug

A

ipratroprium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA: ipratroprium

A
  • blocks action of acetylcholine and creates bronchodilaton
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

indications of ipratroprium

A
  • used for prophylaxis and maintenance therapy
  • NOT a rescue drug
  • often given in combination with albuterol
19
Q

side effects of anticholinergics

A
  • dry
  • hot
  • blind
  • red
  • mad
20
Q

xanthine derivatives

A
  • theophylline
  • aminophylline
21
Q

MOA: xanthine derivatives

A
  • increasing levels of the cAMP enzyme by inhibiting phosphodiesterase
  • stimulates CNS and CVD system
22
Q

side effects of xanthine derivatives

A
  • toxic!!!
  • n/v/d
  • insomnia
  • h/a
  • tachycardia
  • dysrhythmias
  • seizures (more common in elderly)
23
Q

contraindications of xanthine derivatives

A
  • uncontrolled cardiac dysrhythmias
  • seizure disorders
  • hyperthyroid
  • peptic ulcers
24
Q

interactions of xanthine derivatives

A
  • caffeine may increase side effects
  • smoking may decrease absorption
25
Q

nursing considerations for xanthine derivatives

A
  • has a narrow therapeutic index: monitor serum levels and watch for toxicity
  • lots of drug interactions
26
Q

what do leukotrienes do

A
  • they cause inflammation, bronchoconstriction, and mucus production
27
Q

leukotriene receptor antagonist (LTRA) drugs

A
  • montelukast
  • zafirlukast
28
Q

MOA: LTRAs

A
  • prevent leukotrienes from attaching to receptors located on immune cells and within the lungs
  • prevents inflammation
29
Q

what are LTRAs used for

A
  • oral prophylaxis and chronic treatment of asthma in adults and children
  • NOT for acute asthma attacks
  • can also be given for allergies
30
Q

side effects of LTRAs

A
  • headache
  • nausea
  • dizziness
  • insomnia
  • diarrhea
31
Q

LTRAs drug interactions

A
  • montelukast has a few drug-drug interactions
  • zafirlukast has several drug-drug interactions
32
Q

inhaled corticosteroid drugs

A
  • beclomethasone
  • budesonide
  • fluticasone
33
Q

MOA: inhaled corticosteroids

A
  • reduce inflammation and enhance activity of beta agonists
  • also helps with bronchodilaton
34
Q

how long can it take for inhaled corticosteroids to work

A
  • can take several weeks of continuous therapy before full effect of the steroids are realized
35
Q

side effects of inhaled corticosteroids

A
  • pharyngeal irritation
  • coughing
  • dry mouth
  • oral infections
  • RINSE MOUTH AFTER USE
36
Q

what should you teach asthma patients who are using an inhaled corticosteroid

A
  • teach to take on a regular schedule, not PRN and give the bronchodilator first to allow more thorough absorption of the steroids
37
Q

combination: inhaled glucocorticoid and bronchodilator drugs

A
  • budesonide and formoterol
  • fluticasone and salmeterol
38
Q

key teaching for combinations

A
  • used for moderate to severe asthma
  • THESE ARE NEVER FOR ACUTE ATTACKS
39
Q

mast cell stabilizer drug

40
Q

MOA: mast cell stabilizer

A
  • stabilize membranes of mast cells and prevent release of broncho-constrictive inflammatory substances
  • used for prevention of acute asthma attacks
  • 15-20 minutes prior to known triggers
41
Q

monoclonal antibody anti-asthmatic drug

A

omalizumab

42
Q

MOA: monoclonal antibody anti-asthmatic

A
  • monoclonal antibody selectively binds to immunoglobulin IgE which limits the release of mediators of allergic response
43
Q

why must monoclonal antibody anti-asthmatic drugs be monitored closely

A
  • hypersensitivity reactions
  • anaphylaxis is a big risk